Ambryon Biosciences

Catalytically dead Streptococcus pyogenes Cas9 (dCas9)

Catalytically inactive Cas9 that binds DNA at guide-specified sites without cleaving it, produced by the D10A and H840A substitutions in the RuvC and HNH nuclease domains of Streptococcus pyogenes Cas9. Retains 20-nucleotide guide targeting and the NGG PAM requirement, and serves as the programmable DNA-binding scaffold for CRISPRi, CRISPRa, and epigenome editing fusions.

OriginEngineered from Streptococcus pyogenes Cas9 (D10A/H840A)
Sequence HashBd85c6643ae0e674cb7d638656cbed619f6e254bee97e6d7dbe23dbf0eaf12a2
Features[]
Pam SequenceNGG

Characteristics

Binds double-stranded DNA at sites matched by a 20-nucleotide guide sequence next to an NGG PAM but cleaves neither strand. D10A inactivates the RuvC-like domain, which cuts the noncomplementary strand, and H840A inactivates the HNH domain, which cuts the guide-complementary strand; either substitution on its own leaves a nickase that cuts one strand. Binding is reversible and leaves no mutation at the target site. Bound dCas9 blocks transcription by steric occlusion alone. In Escherichia coli, a single sgRNA against the nontemplate strand of a reporter open reading frame gives 10- to 300-fold repression and two sgRNAs together up to 1,000-fold, while the same approach in HEK293 cells gives only 46-63% repression without a fused repressor domain.

Applications

CRISPRi with a fused KRAB repressor reaches 90-99% knockdown of endogenous human genes, and genome-scale CRISPRi and CRISPRa libraries covering every annotated human gene support pooled screening for growth and toxin sensitivity. CRISPRa fusions to VP64, the tripartite VPR activator, or SunTag-recruited activators raise target expression 10- to 10,000-fold. Epigenome editing fusions deposit H3K27ac (dCas9-p300) or CpG methylation (dCas9-Dnmt3a-Dnmt3L), or remove methylation in vivo (dCas9-TET1).

Limitations

CRISPRi repression requires the guide to land between -50 and +300 bp of the transcription start site, and within an open reading frame only nontemplate-strand guides repress. Each sgRNA also directs dCas9 to tens to thousands of off-target sites in mouse embryonic stem cells, needing only a 5-nucleotide PAM-proximal seed match plus an NGG PAM; 70% lie within genes. The original CRISPRi dCas9 carries H841A, not H840A.

Sequence4,104 bp

Sign in to view the full sequence.

Sign in

References

  1. 1.Stepper et al. (2017). Efficient targeted DNA methylation with chimeric dCas9-Dnmt3a-Dnmt3L methyltransferase. Nucleic Acids Res — Stepper 2017 DNMT3A
  2. 2.Morita et al. (2016). Targeted DNA demethylation in vivo using dCas9-peptide repeat and scFv-TET1 catalytic domain fusions. Nat Biotechnol — Morita 2016 TET1
  3. 3.Chavez et al. (2015). Highly efficient Cas9-mediated transcriptional programming. Nat Methods — Chavez 2015 VPR
  4. 4.Hilton et al. (2015). Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat Biotechnol — Hilton 2015 p300
  5. 5.Gilbert et al. (2014). Genome-scale CRISPR-mediated control of gene repression and activation. Cell — Gilbert 2014 CRISPR Screen
  6. 6.Tanenbaum et al. (2014). A protein-tagging system for signal amplification in gene expression and fluorescence imaging. Cell — Tanenbaum 2014 SunTag
  7. 7.Mali et al. (2013). CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol — Mali 2013 Cas9 Nickase
  8. 8.Jinek et al. (2012). A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science — Jinek 2012 SpCas9

Identifiers & revision